Stentless vs. stented bioprosthesis for aortic valve replacement: A case matched comparison of long-term follow-up and subgroup analysis of patients with native valve endocarditis - Fig 1

<p><b>Kaplan-Meier survival curve for survival comparison of Sorin Freedom Solo and Carpentier Edwards Perimount bioprosthetic heart valves (A) and survival probability for patients with or without re-do surgery after index procedure [no = without re-do surgery; yes = with re-do surgery] (B)</b>.</p

Baseline demographics and matching results.

<p>Baseline demographics and matching results.</p

Clinical 30-day outcome and echocardiographic results at discharge.

<p>Clinical 30-day outcome and echocardiographic results at discharge.</p

Forest-plot of multivariate COX-analysis with inclusion of four parameters; NVE native valve endocarditis.

<p>Forest-plot of multivariate COX-analysis with inclusion of four parameters; NVE native valve endocarditis.</p

Periprocedural data.

<p>Periprocedural data.</p

Model-based probabilities of mortality by virus type and variant.

Wild-type to delta infection increased the risk for in-hospital mortality compared to influenza infection or omicron variant infection. Infection with the omicron variant was also associated with higher mortality, but the difference to influenza infection remains moderate.</p

Model summary: Prediction of mortality.

BackgroundWith the emergence of new subvariants, the disease severity of Severe Acute Respiratory Syndrome Coronavirus-2 has attenuated. This study aimed to compare the disease severity in patients hospitalized with omicron variant infection to those with influenza infection.MethodsWe compared data from the multicenter observational, prospective, epidemiological “CORONA Germany” (Clinical Outcome and Risk in hospitalized COVID-19 patients) study on patients infected with Severe Acute Respiratory Syndrome Coronavirus-2 to retrospective data on influenza infection cases from November 2016 to August 2022. Severe Acute Respiratory Syndrome Coronavirus-2 cases were classified as wild-type/delta variant before January 2022, or omicron variant from January 2022 onward. The primary outcome was in-hospital mortality, adjusted for age, gender, and comorbidities.ResultsThe study included 35,806 patients from 53 hospitals in Germany, including 4,916 patients (13.7%) with influenza infection, 16,654 patients (46.5%) with wild-type/delta variant infection, and 14,236 patients (39.8%) with omicron variant infection. In-hospital mortality was highest in patients with wild-type/delta variant infection (16.8%), followed by patients with omicron variant infection (8.4%) and patients with influenza infection (4.7%). In the adjusted analysis, higher age was the strongest predictor for in-hospital mortality (age 80 years vs. age 50 years: OR 4.25, 95% CI 3.10–5.83). Both, patients with wild-type/delta variant infection (OR 3.54, 95% CI 3.02–4.15) and patients with omicron variant infection (OR 1.56, 95% CI 1.32–1.84) had a higher risk for in-hospital mortality than patients with influenza infection.ConclusionAfter adjusting for age, gender and comorbidities, patients with wild-type/delta variant infection had the highest risk for in-hospital mortality compared to patients with influenza infection. Even for patients with omicron variant infection, the adjusted risk for in-hospital mortality was higher than for patients with influenza infection. The adjusted risk for in-hospital mortality showed a strong age dependency across all virus types and variants.Trial registration numberNCT04659187.</div

Model summary: Prediction of ventilation and effect sizes.

Model summary: Prediction of ventilation and effect sizes.</p

Data dictionary.

The processed data, labels, variable type and values. (DOCX)</p

Primary and secondary outcomes stratified by virus type and variant.

Primary and secondary outcomes stratified by virus type and variant.</p